Trials / Completed
CompletedNCT01378130
Central Serous Chorioretinopathy: Etiology, Course and Prognosis
Central Serous Chorioretinopathy: An Observational Study About Etiology, Course and Prognosis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- Medical University of Vienna · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Pathogenesis of central serous chorioretinopathy is not entirely understood yet, therefore further investigations are needed. During this study patients with an acute episode of central serous chorioretinopathy are observed with established ophthalmologic methods (multimodal imagine) every 6 weeks until subretinal fluid is reabsorbed to gain further insides in etiology, course and prognosis of this disease.
Detailed description
Patients with central serous chorioretinopathy are recruited from the Department of Ophthalmology at the Medical University of Vienna. All patients undergo ETDRS visual acuity measurement, Pelli-Robson contrast examination, Amsler-Grid testing, questionnaire testing, ophthalmologic examination, SD-OCT and polarization-sensitive OCT, fundus autofluorescence, fluorescein angiography, indocyanine-green angiography, fundus photo and microperimetry. Patients are re-examined after an interval of 6 weeks until subretinal fluid is entirely reabsorbed to gain further insides in etiology, course and prognosis of this disease.
Conditions
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2013-04-01
- Completion
- 2013-04-01
- First posted
- 2011-06-22
- Last updated
- 2013-04-26
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT01378130. Inclusion in this directory is not an endorsement.